Markets
BSE See NSE See 32,028.89
124.49 (0.39%)
collapse Related Readings collapse

Aurobindo Pharma Gets USFDA Approval For Generic Diovan HCT

By Shrikant Akolkar | 3/22/2013 3:42 PM Friday

Aurobindo Pharma has reported receiving final approval for the Valsartan and Hydrochlorothiazide tablets (brand name Diovan HCT held by Novartis). The drug is indicated in the treatment of hypertension to lower blood pressure. The market size of this drug is USD 1.7 billion (Rs 9350 crore) as per the company’s BSE filings. Aurobindo has said that the product is ready for launch and that this will happen soon.

Drug major Mylan has already launched an authorised generic version of this drug in USA. We believe that Aurobindo is the first to launch the generic of this drug considering that Mylan’s was an authorised generic.

We spoke to the company spokesperson, who declined to comment on the pricing and market share of the drug. However, he did say that the company expects to see about 3-4 generic players in the market. Considering this, about 20% market share looks achievable for Aurobindo. Since it is the first to launch, there would not be a massive erosion of price initially. However, as the drug has already fallen out of patent cover, new players would try to enter the market as faster as possible. Once other companies start launching their versions of the drug, the price will go down.

Considering 80% price erosion and 10% market share for Aurobindo, it can be estimated that the company may achieve revenues of about Rs 700 crore from the drug. Of course, these numbers are based on the assumption that the company makes the best of this opportunity.

With this approval, Aurobindo Pharma has a total of 181 ANDA approvals from USFDA, of which 156 are final and 25 are tentative approvals.

 

Find More Articles on: Markets, DSIJ Mindshare, Product, Large Cap

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

Quarterly results: Persistent Systems

Quarterly results: Persistent Systems

The company's total sales for Q1FY18 came in at Rs 728 crore, which represents a 0.12 per cent sequential increase and 3.75 per cent YoY increase.

Overnight Digest: Stocks to look out for on July 24

Overnight Digest: Stocks to look out for on July 24

The stocks that are likely to witness significant movement on the bourses on July 24 are Tata Teleservices (Maharashtra) Limited, Coffee Day Enterprises Limited, Vedanta Limited, Onward Technologies Limited and Persistent Systems Limited.

Q1FY18 Results: Indian Bank

Q1FY18 Results: Indian Bank

The bank's NII for the quarter improved by 5.4 per cent QoQ to Rs 1459 crore on the back of rise in interest earned at Rs.4135 crore as compared to the slow rise in interest expended to Rs.2676 crore in Q1FY18.

Nifty, Sensex recoup losses to end on a positive note; Sterlite Technologies, Wipro up by over 7 per cent

Nifty, Sensex recoup losses to end on a positive note; Sterlite Technologies, Wipro up by over 7 per cent

Indian benchmark indices Nifty and Sensex declined to intra-day lows of 9846.90 and 318,815.50, respectively, but staged a smart recovery in the closing hours.

Q1FY18 Result : Atul Limited

Q1FY18 Result : Atul Limited

The company's total sales for Q1FY18 came in at Rs 690.1 crore, which represents a 9 per cent sequential decline and 2.2 per cent YoY increase.

Q1FY18 Results: Ashok Leyland Ltd.

Q1FY18 Results: Ashok Leyland Ltd.

The company's total sales for Q1FY18 came in at Rs 4514 crore, which represents a 36.04 per cent sequential decline and 0.38 per cent YoY decline.

Can Fin Homes Ltd: Q1FY18 Results

Can Fin Homes Ltd: Q1FY18 Results

The company reported NII growth of 0.7% QoQ to Rs 135.5 crore for Q1FY2017-18. Its NII for the quarter ended March 31, 2017, was Rs 134.5 crore. The company's net profit for the quarter grew marginally by 0.5% QoQ to Rs 71.2 crore.

Dewan Housing Finance Corp Ltd: Q1FY18 Results

Dewan Housing Finance Corp Ltd: Q1FY18 Results

The company reported NII de-growth of 1.3% QoQ to Rs 619.71 crore for Q1FY2017-18. Its NII for the quarter ended March 31, 2017 was Rs 627.91 crore.

Buzzing stock: Jaiprakash Associates hits new 52-week high

Buzzing stock: Jaiprakash Associates hits new 52-week high

Today, the stock has surged by 17.35 percent from its previous closing price of Rs 23.05. It has touched a 52-week high of Rs 27.20.

MF industry receives Rs 4,600 crore a month via SIPs

MF industry receives Rs 4,600 crore a month via SIPs

The AMFI data, coming as a good news for the Rs 19 crore MF industry, stated that the industry has posted an average monthly inflow of Rs 4,564 crore through SIPs, for the three-month period from April to June 2017.